Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer

Conclusion: For c-Met–targeted SPECT imaging of NSCLC, we developed 99mTc-HYNIC-cMBP, a tracer that specifically binds to c-Met with favorable pharmacokinetics in vitro and in vivo.

Source: Journal of Nuclear Medicine - November 1, 2018 Category: Nuclear Medicine Authors: Han, Z., Xiao, Y., Wang, K., Yan, J., Xiao, Z., Fang, F., Jin, Z., Liu, Y., Sun, X., Shen, B. Tags: Basic Source Type: research